Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms |
Target |
Action inhibitors |
Mechanism BTK inhibitors(Tyrosine-protein kinase BTK inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC43H45N9O6 |
InChIKeyZKOLOVUMLBKGOH-TUDONDPESA-N |
CAS Registry2360561-77-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Hodgkin Lymphoma | Preclinical | China | 06 Jun 2018 |